ARINA-1

N/A

Report date: 2025/05/12 16:57:53

Base Information

Drug NameARINA-1
Drug Alias Name88 mg/mL ascorbic acid, ASC; 150 mg/mL reduced glutathione, GSHBicarbonate/glutathione/ascorbic acid inhalationGlutathione/bicarbonate/ascorbic acid inhalationInhaled L-glutathioneARINA-1
ClassificationSmall molecules
Mechanisms of ActionNuclear factor NF-kappa-B complex modulators
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsRejection of lung transplantationBronchiolitis ObliteransBronchiectasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesRenovion IncUniversity Of North Carolina At Chapel Hill
China Registration ClassN/A

Develop Information

Active CompaniesRenovion Inc
Inactive CompaniesDuke University
Active IndicationsBronchiolitis ObliteransBronchiectasis
Inactive IndicationsRejection of lung transplantation

Other Information

ATC CodeN/A
Related LinksN/A